Accès ouvert déclaré
2024
article
Impact of essential genes on the success of genome editing experiments generating 3313 new genetically engineered mouse lines
Hillary Elrick, Kevin A. Peterson, Brandon Willis, Denise G. Lanza, Elif F. Acar, Edward J. Ryder, Lydia Teboul, Petr Kašpárek, Marie‐Christine Birling, David J. Adams, Allan Bradley, Robert E. Braun, Steve D. M. Brown, Adam Caulder, Gemma Codner, Francesco J. DeMayo, Mary E. Dickinson, Brendan Doe, Graham Duddy, Marina Gertsenstein, Leslie O. Goodwin, Yann Hérault, Lauri G. Lintott, K. C. Kent Lloyd, Isabel Lorenzo, Matthew Mackenzie, Ann‐Marie Mallon, Colin McKerlie, Helen Parkinson, Ramiro Ramírez‐Solis, John R. Seavitt, Radislav Sedláček, William C. Skarnes, D. Smedley, Sara Wells, Jacqueline K. White, Joshua A. Wood, Shaheen Akhtar, Alasdair J. Allan, Susan Allen, Philippe André, D. E. Archer, Sarah Atkins, Ruth Avery, Abdel Ayadi, Daniel M. Barrett, Tanya Beyetinova, Melissa L. Berry, Katharina Boroviak, Joanna Bottomley, Tim Brendler-Spaeth, Ellen Brown, Jonathan Burvill, James Bussell, Charis Cardeno, R. Carter, Patricia Castellanos-Penton, Skevoulla Christou, Greg Clark, Shannon Clarke, James Cleak, Amie Creighton, Maribelle Cruz, Ozge Danisment, Charlotte Davis, Joanne Doran, Valérie Erbs, Qing Fan-Lan, Rachel Fell, Feng He, Jean-Victor Fougerolle, Alex Fower, Gemma Frake, Martin Fray, Antonella Galli, David Gannon, Wendy Gardiner, Angelina Gaspero, Diane Gleeson, Chris Godbehere, Evelyn Grau, Mark Griffiths, Nicola Griggs, Kristin Grimsrud, Sarah Hazeltine, Marie Hutchison, Catherine Ingle, Vivek Iyer, Kathrin Jäger, Joanna Joeng, Susan Kales, Janet Kenyon, Jana Kopkanova, Christelle Kujath, Peter M. Kutny, Valerie Laurin, Sandrine Lejeay, Christopher J. Lelliott, Jorik Loeffler, Romain Lorentz, Christopher V. McCabe, Elke Malzer, Peter Matthews, Ryea Maswood, Matthew McKay, Terrence F. Meehan, David Melvin, Alison Murphy, Asif Nakhuda, Amit Patel, Ilya Paulavets, Guillaume Pavlovic, Ashley Pawelka, Fran J. Pike, Radka Platte, Peter D. Price, Kiran Rajaya, Shalini Kamu Reddy, Whitney Rich, Barry P. Rosen, Victoria Ross, Mark Ruhe, Luís Santos, Laurence Schaeffer, Alix Schwiening, Mohammed Selloum, Debarati Sethi, Jan R. Sidiangco, Caroline Sinclair, Elodie Sins, Gillian Sleep, Tania Sorg, Becky Starbuck, Michelle Stewart, Holly Swash, Mark Thomas, Sandra Tondat, Rachel Urban, Jana Urbanová, Susan Varley, Hannah Wardle‐Jones, Lauren Weavers, Michael Woods, Stephen A. Murray, Jason D. Heaney, Lauryl M. J. Nutter
8Citations signalées — pas une note de qualité
28Institutions déclarées
5Pays d’affiliation déclarés
Résumé fourni par la source
The International Mouse Phenotyping Consortium (IMPC) systematically produces and phenotypes mouse lines with presumptive null mutations to provide insight into gene function. The IMPC now uses the programmable RNA-guided nuclease Cas9 for its increased capacity and flexibility to efficiently generate null alleles in the C57BL/6N strain. In addition to being a valuable novel and accessible research resource, the production of 3313 knockout mouse lines using comparable protocols provides a rich dataset to analyze experimental and biological variables affecting in vivo gene engineering with Cas9. Mouse line production has two critical steps - generation of founders with the desired allele and germline transmission (GLT) of that allele from founders to offspring. A systematic evaluation of the variables impacting success rates identified gene essentiality as the primary factor influencing successful production of null alleles. Collectively, our findings provide best practice recommendations for using Cas9 to generate alleles in mouse essential genes, many of which are orthologs of genes linked to human disease.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Impact of essential genes on the success of genome editing experiments generating 3313 new genetically engineered mouse lines
- Date Crossref
- 30/09/2024
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.
Institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.
Sujets associés
CRISPR and Genetic EngineeringVirus-based gene therapy researchRNA and protein synthesis mechanisms